TABLE 3.
Adverse events due to guideline nonadherence in high- and intermediate-risk chemotherapy initiations in which primary prophylaxis was indicated
| Regimen risk | No. of nonadherent regimens | Neutropenic episode with dose delay, n (%) | Neutropenic episode without dose delay, n (%) | Febrile neutropenia with hospital admission, n (%) |
|---|---|---|---|---|
| High | 5 | 0 (0) | 0 (0) | 2 (40) |
| Intermediate + at least 1 risk factor | 59 | 7 (11.9) | 5 (8.5) | 3 (5.1) |
| Total | 64 | 7 (10.9) | 5 (7.8) | 5 (7.8) |